Consistent with these trends, psoriasis-specific and non-specific DEGPs were oppositely regulated by RNA interference treatments targeting pro- and anti-differentiation genes, respectively (e.g., SNAI2, ANCR, STAU, ZNF750; Additional file 18). The gene discussed is SNAI2; the disease is psoriasis.